Deep Dive: Deep Dive Into Medical Cannabis and Veterans
January 20th 2023
One of the recurring challenges in the medical cannabis space is the access for patients—from affordability to medical advice on what to use, patients need help. Veterans also have a unique challenge regarding access to medical cannabis if they have medical coverage through the VA. Veteran Cherissa Jackson of WE DECODE LLC sheds some light on these issues, hopes for the future, and her role as the medical cannabis program chair at the Cannabis Science Conference series this year.
Behind the Science: Behind Key Takeaways from ASH
January 19th 2023
Experts discuss their key takeaways and highlight important abstracts presented at the 2022 ASH Annual Meeting.
Deep Dive: Deep Dive Into Chronic Fatigue
Fibromyalgia, long COVID, and chronic fatigue syndrome have many of the same symptoms, so how do they differ? Where do they come from? And how are they differentiated? Infection Control Today® spoke with Seth Lederman, MD, a rheumatologist to answer questions about these 3 conditions.
Wellbeing Checkup: Postpartum Depression
January 18th 2023
Postpartum depression (PPD) and major depressive disorder (MDD) in pregnant and postpartum women are severely underdiagnosed and undertreated. What can we do to help these patients? In this episode of Wellbeing Checkup, Anita Clayton, MD, of the University of Virginia and Nathan Bryson, PhD, of Reunion Neuroscience discuss PPD and MDD diagnoses in pregnant and postpartum patients, as well as the potential of more convenient, faster-acting psychedelic-derived treatments for PPD and MDD.
Deep Dive: Deep Dive Into Maui Derm
As the 2023 Dermatology Conference season kicks off this month, Dermatology Times talks to George Martin, MD. He founded Maui Derm, for Dermatologists: touted as the premiere, fully accredited CME conference that teaches a cutting-edge blend of medical and cosmetic dermatology advances by a world-class faculty. Martin talks about the 2 winter conferences: Maui Derm Caribbean in Aruba and Maui Derm Hawaii and why he developed them.
Behind the Science: Behind Breaking the Cycle of Recurrent C Difficile
January 17th 2023
The healthcare-associated infection, C difficile, can be especially problematic for patients and clinicians. It is estimated that between 15% to 30% of patients who respond to antibiotics experience recurrent C difficile. And a second recurrence rate of 40% can happen to those who have a resolved first recurrence. This subset of patients who get additional recurrences can begin to experience a revolving door of healthcare interactions, diminished quality of life, and severe health consequences. In this video segment, clinicians and stakeholders offer some insights for how a biotherapeutic could help these patients.
Deep Dive: Deep Dive Into Vaccine Hesitant Patients
Charlotte Moser, co-director of the Vaccine Education Center and creator or the Parents PACK program at the Children’s Hospital of Philadelphia (CHOP), explores vaccine hesitancy. She explains the historic habit and modern landscape of vaccine hesitancy while providing helpful suggestions on how to approach vaccine hesitant patients.
Wellbeing Checkup: Recognizing Cognitive Decline
January 16th 2023
Dr. Sharon Cohen stresses the importance of recognizing and raising awareness of cognitive decline. Medical director of the Toronto Memory Program, Dr. Cohen provides perspective on the need for therapies like lecanemab and access to them at the earliest stages of decline.
Behind the Science: Behind Value-Based Care Programs
December 8th 2022
Many payers have value-based care programs that aim to drive meaningful improvements in patient care, but differences in structures and requirements can leave practices with an unbalanced focus on program requirements and prove more burdensome. On this week’s Behind the Science, experts discuss findings of a recently authored white paper from The US Oncology Network on the benefits and challenges of engaging with multiple payers and various value-based care programs on a quality value-based care strategy that ensures quality patient care while minimizing practice burden.
Deep Dive: Deep Dive Into RBX2660
The FDA approved RBX2660 for the prevention of recurrent CDI last week, making it the first ever approved live microbiota therapeutic. Dr. Sahil Khanna was an investigator on the PUNCH CD3 study testing the product and spoke about the excitement of the drug and why it might result in a significant reduction in C difficile cases in the coming years.
MWN Medical Minutes: December 8, 2022
Formic Acid Identified As Urinary Biomarker For Early-Stage Alzheimer’s Disease | High Sugar Intake May Lead To Premature Aging In Childhood Cancer Survivors | Parent-Pediatrician Vaccine Discussions Are Lagging, National Poll Finds
Wellbeing Checkup: Hope for Chronic Pain
December 7th 2022
It is estimated that up to 20% of US adults are dealing with chronic pain and 8% of US Adults have high-impact chronic pain. Many people with chronic pain have turned to opioids to treat their pain, but along with the highly addictive quality of these class of medications, there are toxicities that affect the organs from long-term usage and create additional medical issues. Dr. Hernan Bazan discusses the issues associated with suffering from chronic pain and daily use of opioids, offers some insights on traditional pain relievers, and how the next generation of therapies in development need to be a safe, potential alternative from opioids.
Deep Dive: Deep Dive Into Research and Development
Dr. Patricia Piers, head of R&D, Ophthalmic Implants at Johnson & Johnson Surgical Vision, recently received the 2022 Women in Ophthalmology Scientific Contribution Award. This award recognizes a physician or non-physician scientist who has made significant contribution in the field of ophthalmology.
Wellbeing Checkup: Burnout in the Radiation Oncology Field
December 6th 2022
During the 2022 American Society for Radiation Oncology Annual Meeting, experts in oncology gave presentation on working hours, increased patient volume and contact, decreased autonomy at work, and increased professional expectations in radiation oncology. Bridget Koontz, MD of GenesisCare provide key takeaways.
Behind the Science: Behind the 2022 SDPA Conference
December 5th 2022
The 2022 Society of Dermatology Physician Assistants (SDPA) Conference was held in Miami, Florida from November 17th to November 20th. Several speakers and attendees spoke about the importance of the information shared at the conference; whether it be a session they’re holding or the exciting advancements and breakthroughs we can look forward to, in dermatology, moving into the new year.
Deep Dive: Deep Dive Into Remdesivir for the Treatment of Severe COVID-19
November 17th 2022
Dr. Elizabeth Sapey provides an in-depth look at the World Health Organization’s recent decision to recommend the use of remdesivir in patients with severe COVID-19, including results from the PINETREE study that were the “linchpin” for the change and how she uses remdesivir in her own clinical practice.
Deep Dive: Deep Dive Into Shared Decision-Making for Prostate Cancer Screening
November 16th 2022
Hanan Goldberg, MD, MSc, shares notable findings from the study, “Disparities regarding shared decision making in prostate cancer screening,” which was presented at the 74th annual meeting of the Northeastern Section of the American Urological Association. Goldberg is an assistant professor at SUNY Upstate Medical University in Syracuse, New York.
Behind the Science: Behind Health Care Environmental Hygiene
November 15th 2022
Along with hand hygiene, health care environmental hygiene is vital to protecting patients’ health while in health care facilities. Infection Control Today spoke to experts who gathered for the Clean Hospitals Day International Conference about the importance of health care environmental hygiene and the challenges that different countries face in fighting health care-acquired infections.
Deep Dive: Deep Dive Into Value-Based Care in Community Oncology Practices
Jay Scott, MD, discusses value-based care, how to implement it, and how to overcome challenges with value-base care.
Behind the Science: Behind the 2022 ECTRIMS Congress
November 14th 2022
2022 marked the 38th Annual Congress of the European Committee for Treatment and Research in Multiple Sclerosis. The NeurologyLive team was on-site in Amsterdam and spoke with a number of experts in the clinical care of patients with MS about some of the hottest topics and presentations at this year’s meeting, including anticipated data in radiologically isolated syndrome, underlying mechanisms of fatigue, the welcome lecture on pediatric MS, postpartum treatment in NMOSD, stem cell transplantation, and teleneurology, among other topics.
Deep Dive: Deep Dive Into Benzene Exposure Risks in Dry Shampoo Products
Multinational consumer goods company Unilever announced a voluntary product recall of various popular dry shampoo aerosol products—including those from brands such as Dove, Nexxus, Suave, TIGI and TRESemmé—due to risk of increased benzene levels, in mid-October. The announced recall, per the FDA, coincided with an internal investigation by the company into the cause of increased benzene exposure risk—identifying the products’ aerosol propellant, provided by an outside supplier, as the source. As the FDA noted, benzene is a human carcinogen that, through increased inhaled, oral or subcutaneous exposure, may increase risk of leukemia and other blood cancers or disorders. While benzene is prevalent in daily indoor and outdoor environments, recalled products generally carry a substantial risk of increased exposure, and the FDA recommends affected consumers stop using recalled products and report adverse reactions to their adverse event reporting program.
Behind the Science: Behind Flu and COVID-19 Shots
November 2nd 2022
The 2022-2023 respiratory virus season is the third in which influenza and COVID-19 are cocirculating. And yet while vaccination remains the best protection against severe infection with—and hospitalization for—both, clinicians still deal with patient reservation, reluctance, and refusal. An infectious disease specialist and 2 primary care physicians have suggestions on how to get shots into arms.
Deep Dive: Deep Dive Into Eye Stroke
On this episode of Deep Dive, retina specialist Gareth Lema, MD, PhD, explains the importance of recognizing the signs and symptoms of eye stroke and timely treatment for patients. He also discusses the role of optical coherence tomography and a novel eye stroke program at Mount Sinai Health System that involves collaboration among ophthalmologists, the stroke service, and emergency department physicians.
Behind the Science: Behind PARP Inhibitors in Breast Cancer
November 1st 2022
On this episode of Behind The Science, a panel of experts discuss PARP inhibitors and see how they fit into the treatment paradigm for breast cancer.
Deep Dive: Deep Dive Into Digital Inhalers
Dr. Giselle Mosnaim discusses a recent study that she worked on. The study looked at the effectiveness of a digital inhaler system in improving adherence and technique to lead to better outcomes in patients with asthma.
Deep Dive: Deep Dive Into Immune Deficiency
October 28th 2022
As treatments for multiple myeloma continue to improve, clinicians must still face a scary reality for their patients: immune deficiency. Researchers and doctors alike are still trying to get a better understanding of which patients are more likely to have severe immune issues, which could lead to life-threatening infections. In this episode of Deep Dive, we’ll hear from Dr. Joshua Richter from the Tisch Cancer Institute at Mount Sinai, about his research in patients with myeloma who have a high burden of infection, and why patient-provider communication is essential in this setting.
Wellbeing Checkup: Racial Disparities in Breast Cancer
October 27th 2022
Bridget A Oppong, MD, discusses how racial disparities play a role in the screening, care, and outcomes of patients with breast cancer.
Deep Dive: Deep Dive Into Business Coalitions Driving Value-Based Care
The rising health care spend is a significant issue facing employers who are accountable for the health care coverage of over 180 million Americans. On today's Deep Dive, Neil Goldfarb, president and CEO of the Greater Philadelphia Business Coalition on Health (GPBCH), discussed the utility of business coalitions in driving transparency for value-based health care, the accomplishments and persistent challenges GPBCH has had so far, and the future impact of these coalitions as health care delivery continues to evolve.
Behind the Science: Behind Advocacy in Oncology Nursing
October 25th 2022
In this episode of Behind The Science, Oncology Nursing News® Met with presenters from the 2022 Oncology Nursing Society Bridge and asked: how oncology nurses can advocate for their peers.
Deep Dive: Deep Dive Into High-Risk Cutaneous Squamous Cell Carcinoma
Sheriff Ibrahim, MD,PhD, provides key pearls from his co-directed session as the 2022 Annual ASDS Meeting, “Defining ‘High-Risk’ for Squamous Cell Carcinoma: Implications for Treatment Paradigms.” Ibrahim is the founder of Rochester Dermatologic Surgery and an associate professor of dermatology at the University of Rochester Medical Center in Rochester, New York.